Ongoing monitoring Health coaches, access to clinicians, and optional blood tests throughout your journey help us keep a close eye on your progress to make sure your treatment is optimised
iScience 26:105717 Kriston L, von Wolff A, Westphal A, Holzel LP, Harter M (2014) Efficacy and acceptability of acute treatments for persistent depressive disorder: a network meta-analysis
The primary end points for part one were (1) resolution of steatohepatitis without worsening of liver fibrosis, and (2) reduction in liver fibrosis without worsening of steatohepatitis Primary outcome: Results In patients with MASH and moderate or advanced liver fibrosis, once-weekly semaglutide at a dose of 2.4 mg improved liver histologic results
Additionally, in vitro studies with pituitary cells suggest a similar increase in GH release upon exposure to DSIP, albeit with a notable decline at higher concentrations